Home - Products - Others - Other Targets - APL1β27 trifluoroacetate salt/APLP1-derived Aβ-like peptide (1-27)

APL1β27 trifluoroacetate salt/APLP1-derived Aβ-like peptide (1-27)

CAS No. 1233876-44-2

APL1β27 trifluoroacetate salt/APLP1-derived Aβ-like peptide (1-27)( ——— )

Catalog No. M40886 CAS No. 1233876-44-2

APL1β27 trifluoroacetate salt/APLP1-derived Aβ-like peptide (1-27)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    APL1β27 trifluoroacetate salt/APLP1-derived Aβ-like peptide (1-27)
  • Note
    Research use only, not for human use.
  • Brief Description
    APL1β27 trifluoroacetate salt/APLP1-derived Aβ-like peptide (1-27)
  • Description
    APL1β27 trifluoroacetate salt/APLP1-derived Aβ-like peptide (1-27)
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    1233876-44-2
  • Formula Weight
    2472.76
  • Molecular Formula
    C103H174N30O38S1
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 3beta-Hydroxyurs-12,...

    The roots of Ilex cornuta.

  • TS-011

    TS-011 is a selective 20-Hydroxyeicosatetraenoic acid synthesis inhibitor.

  • Tozorakimab

    Tozorakimab (MEDI-3506) is a human immunoglobulin G1 monoclonal antibody targeting IL-33. It inhibits IL-33 signaling through ST2 and RAGE/EGFR, reduces inflammation and epithelial dysfunction, and can be used to study chronic obstructive pulmonary disease.